Fundamental role for HIF-1α in constitutive expression of human β defensin-1

Mucosal Immunology

Volumn 6, Issue 6, 2013, Pages 1110-1118

  Kelly, C J ^a   Glover, L E ^a   Campbell, E L ^a   Kominsky, D J ^a   Ehrentraut, S F ^a   Bowers, B E ^a   Bayless, A J ^a   Saeedi, B J ^a   Colgan, S P ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN 1; GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ANIMAL EXPERIMENT; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA STRUCTURE; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA RESPONSE ELEMENT; INTESTINE EPITHELIUM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION REGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANOXIA; BETA-DEFENSINS; CACO-2 CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INTESTINAL MUCOSA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, ANIMAL; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; TRANSCRIPTIONAL ACTIVATION;

EID: 84884236749     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2013.6     Document Type: Article

References (40)

1. Colgan, S.P. & Taylor, C.T. Hypoxia: An alarm signal during intestinal inflammation. Nat. Rev. Gastroenterol. Hepatol. 7, 281-287 (2010).
2. Mastrogiannaki, M., Matak, P., Keith, B., Simon, M.C., Vaulont, S. & Peyssonnaux, C. HIF-2alpha, but not HIF-1alpha, promotes iron absorption in mice. J. Clin. Invest. 119, 1159-1166 (2009).
3. Comerford, K.M.,Wallace, T.J., Karhausen, J., Louis, N.A., Montalto,M.C. & Colgan, S.P. Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res. 62, 3387-3394 (2002).
4. Louis, N.A., Hamilton, K.E., Canny, G., Shekels, L.L., Ho, S.B. & Colgan, S.P. Selective induction of mucin-3 by hypoxia in intestinal epithelia. J. Cell. Biochem. 99, 1616-1627 (2006).
5. Furuta, G.T. et al. Hypoxia-inducible factor 1-dependent induction of intestinal trefoil factor protects barrier function during hypoxia. J. Exp. Med. 193, 1027-1034 (2001).
6. Pazgier, M., Hoover, D.M., Yang, D., Lu, W. & Lubkowski, J. Human betadefensins. Cell. Mol. Life Sci. 63, 1294-1313 (2006).
7. Ganz, T. Defensins: Antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 3, 710-720 (2003).
8. Schroeder, B.O. et al. Reduction of disulphide bonds unmasks potent antimicrobial activity of human beta-defensin 1. Nature 469, 419-423 (2011).
9. Harder, J., Bartels, J., Christophers, E. & Schroder, J.M. Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic. J. Biol. Chem. 276, 5707-5713 (2001).
10. O'Neil, D.A. et al. Expression and regulation of the human beta-defensins hBD-1 and hBD-2 in intestinal epithelium. J. Immunol. 163, 6718-6724 (1999).
11. Zhao, C., Wang, I. & Lehrer, R.I. Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells. FEBS Lett. 396, 319-322 (1996).
12. Peyrin-Biroulet, L. et al. Peroxisome proliferator-Activated receptor gamma activation is required for maintenance of innate antimicrobial immunity in the colon. Proc. Natl. Acad. Sci. USA 107, 8772-8777 (2010).
13. Kocsis, A.K. et al. Association of beta-defensin 1 single nucleotide polymorphisms with Crohn's disease. Scand. J. Gastroenterol. 43, 299-307 (2008).
14. Wehkamp, J. et al. Inducible and constitutive beta-defensins are differentially expressed in Crohn's disease and ulcerative colitis. Inflamm. Bowel Dis. 9, 215-223 (2003).
15. Jurevic, R.J., Bai, M., Chadwick, R.B., White, T.C. & Dale, B.A. Singlenucleotide polymorphisms (SNPs) in human beta-defensin 1: Highthroughput SNP assays and association with Candida carriage in type I diabetics and nondiabetic controls. J. Clin. Microbiol. 41, 90-96 (2003).
16. Schaefer, A.S. et al. A 3' UTR transition within DEFB1 is associated with chronic and aggressive periodontitis. Genes Immun. 11, 45-54 (2010).
17. Ozturk, A., Famili, P. & Vieira, A.R. The antimicrobial peptide DEFB1 is associated with caries. J. Dent. Res. 89, 631-636 (2010).
18. Karhausen, J., Furuta, G.T., Tomaszewski, J.E., Johnson, R.S., Colgan, S.P. & Haase, V.H. Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis. J. Clin. Invest. 114, 1098-1106 (2004).
19. Keely, S. et al. Hypoxia-inducible factor-dependent regulation of plateletactivating factor receptor as a route for gram-positive bacterial translocation across epithelia. Mol. Biol. Cell 21, 538-546 (2010).
20. Flashman, E., Davies, S.L., Yeoh, K.K. & Schofield, C.J. Investigating the dependence of the hypoxia-inducible factor hydroxylases (factor inhibiting HIF and prolyl hydroxylase domain 2) on ascorbate and other reducing agents. Biochem. J. 427, 135-142 (2010).
21. Goldman, M.J., Anderson, G.M., Stolzenberg, E.D., Kari, U.P., Zasloff, M. & Wilson, J.M. Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 88, 553-560 (1997).
22. Morrison, G.M. et al. Mouse beta defensin-1 is a functional homolog of human beta defensin-1. Mamm. Genome 9, 453-457 (1998).
23. Huttner, K.M., Kozak, C.A. & Bevins, C.L. The mouse genome encodes a single homolog of the antimicrobial peptide human beta-defensin 1. FEBS Lett. 413, 45-49 (1997).
24. Wood, S.M. et al. Selection and analysis of amutant cell line defective in the hypoxia- inducible factor-1 alpha-subunit (HIF-1alpha). Characterization of hif- 1alpha-dependent and -independent hypoxia-inducible gene expression. J. Biol. Chem. 273, 8360-8368 (1998).
25. Yoshikawa, T., Inoue, R.,Matsumoto,M., Yajima, T., Ushida, K. & Iwanaga, T. Comparative expression of hexose transporters (SGLT1, GLUT1, GLUT2 and GLUT5) throughout the mouse gastrointestinal tract. Histochem. Cell Biol. 135, 183-194 (2011).
26. Malik, A.N. & Al-Kafaji, G. Glucose regulation of beta-defensin-1 mRNA in human renal cells. Biochem. Biophys. Res. Commun. 353, 318-323 (2007).
27. Taylor, C.T. & Colgan, S.P. Hypoxia and gastrointestinal disease. J. Mol. Med. (Berl) 85, 1295-1300 (2007).
28. Benita, Y., Kikuchi, H., Smith, A.D., Zhang, M.Q., Chung, D.C. & Xavier, R.J. An integrative genomics approach identifies hypoxia inducible factor-1 (HIF-1)-Target genes that form the core response to hypoxia. Nucleic Acids Res. 37, 4587-4602 (2009).
29. Bruning, U. et al. MicroRNA-155 promotes resolution of hypoxia-inducible factor 1alpha activity during prolonged hypoxia. Mol. Cell. Biol. 31, 4087-4096 (2011).
30. Nytko K.J., Maeda, N., Schlafli, P., Spielmann, P., Wenger, R.H. & Stiehl, D.P. Vitamin C is dispensable for oxygen sensing in vivo. Blood 117, 5485-5493 (2011).
31. Gires, O. et al. Tumor necrosis factor alpha negatively regulates the expression of the carcinoma-Associated antigen epithelial cell adhesion molecule. Cancer 92, 620-628 (2001).
32. Cummins, E.P. et al. The hydroxylase inhibitor dimethyloxalylglycine is protective in amurine model of colitis. Gastroenterology134, 156-165 (2008).
33. Hindryckx, P. et al. Hydroxylase inhibition abrogates TNF-Alpha-induced intestinal epithelial damage by hypoxia-inducible factor-1-dependent repression of FADD. J. Immunol. 185, 6306-6316 (2010).
34. Robinson, A.,Keely, S., Karhausen, J., Gerich, M.E., Furuta, G.T. Colgan, S.P. Mucosal protection by hypoxia-inducible factor prolyl hydroxylase inhibition. Gastroenterology 134, 145-155 (2008).
35. Andresen, E., Gunther, G., Bullwinkel, J., Lange, C. & Heine, H. Increased expression of beta-defensin 1 (DEFB1) in chronic obstructive pulmonary disease. PLoS One 6, e21898 (2011).
36. Vislisel, J.M., Schafer, F.Q.Buettner,G.R.A simple and sensitive assay for ascorbate using a plate reader. Anal. Biochem. 365, 31-39 (2007).
37. Keely, S. et al. Hypoxia-inducible factor-dependent regulation of plateletactivating factor receptor as a route for gram-positive bacterial translocation across epithelia. Mol. Biol. Cell 21, 538-546 (2009).
38. MacManus, C.F., Campbell, E.L., Keely, S., Burgess, A., Kominsky, D.J. & Colgan, S.P. Anti-inflammatory actions of adrenomedullin through fine tuning of HIF stabilization. FASEB J. 25, 1856-1864 (2011).
39. Rosenberger, P., Khoury, J., Kong, T., Weissmuller, T., Robinson, A.M. & Colgan, S.P. Identification of vasodilator-stimulated phosphoprotein (VASP) as an HIF-regulated tissue permeability factor during hypoxia. FASEB J. 21, 2613-2621 (2007).
40. Sheta, E.A., Trout, H., Gildea, J.J., Harding, M.A. & Theodorescu, D. Cell density mediated pericellular hypoxia leads to induction of HIF-1alpha via nitric oxide and Ras/MAP kinase mediated signaling pathways. Oncogene 20, 7624-7634 (2001).